Solution structure of human myeloid-derived growth factor suggests a conserved function in the endoplasmic reticulum.
Valeriu BortnovMarco TonelliWoonghee LeeZiqing LinDouglas S AnnisOmar N DemerdashAlex BatemanJulie C MitchellYing GeJohn L MarkleyDeane F MosherPublished in: Nature communications (2019)
Human myeloid-derived growth factor (hMYDGF) is a 142-residue protein with a C-terminal endoplasmic reticulum (ER) retention sequence (ERS). Extracellular MYDGF mediates cardiac repair in mice after anoxic injury. Although homologs of hMYDGF are found in eukaryotes as distant as protozoans, its structure and function are unknown. Here we present the NMR solution structure of hMYDGF, which consists of a short α-helix and ten β-strands distributed in three β-sheets. Conserved residues map to the unstructured ERS, loops on the face opposite the ERS, and the surface of a cavity underneath the conserved loops. The only protein or portion of a protein known to have a similar fold is the base domain of VNN1. We suggest, in analogy to the tethering of the VNN1 nitrilase domain to the plasma membrane via its base domain, that MYDGF complexed to the KDEL receptor binds cargo via its conserved residues for transport to the ER.
Keyphrases
- endoplasmic reticulum
- growth factor
- transcription factor
- endothelial cells
- amino acid
- protein protein
- binding protein
- bone marrow
- dendritic cells
- acute myeloid leukemia
- induced pluripotent stem cells
- magnetic resonance
- left ventricular
- pluripotent stem cells
- small molecule
- high resolution
- metabolic syndrome
- dna binding
- heart failure
- adipose tissue
- skeletal muscle
- immune response
- atrial fibrillation
- breast cancer cells